GRI BIO, Inc.
La Jolla, CA
LAST FUNDING
$762K
Series A
Funding history
DateRoundAmountInvestorsSource
—Series A$762K——
About GRI BIO, Inc.
How much funding has GRI BIO, Inc. raised?
GRI BIO, Inc. has raised $762K in total funding. The most recent round was Series A.
Where is GRI BIO, Inc. headquartered?
GRI BIO, Inc. is headquartered in La Jolla, CA.
What makes GRI BIO, Inc. notable?
GRI Bio is a publicly traded clinical-stage biopharmaceutical company (Nasdaq: GRI), led by CEO Marc Hertz, PhD.
Leadership
Walter Hertz
Executive Officer, Director
Leanne Kelly
Executive Officer
David Baker
Director
Roelof Rongen
Director
Camilla Simpson
Director
David Szekeres
Director
Avenzo Therapeutics, Inc.
San Diego, CA
ImmunityBio, Inc.
San Diego, CA
Mirador Therapeutics, Inc.
San Diego, CA
Avidity Biosciences, Inc.
San Diego, CA
Inhibrx, Inc.
Healthcare
Enlaza Therapeutics, Inc.
Healthcare
Alume Biosciences Inc
Healthcare
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.
MLA
"GRI BIO, Inc.: Funding & Investors." SoCal.Startups, August 27, 2026, https://socalstartups.io/companies/city/la-jolla/healthcare/gri-bio-inc. Accessed August 27, 2026.
APA
SoCal.Startups. (2026). GRI BIO, Inc.: Funding & Investors. Retrieved August 27, 2026, from https://socalstartups.io/companies/city/la-jolla/healthcare/gri-bio-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=GRI BIO, Inc.: Funding & Investors |url=https://socalstartups.io/companies/city/la-jolla/healthcare/gri-bio-inc |website=SoCal.Startups |access-date=August 27, 2026}}